| Revenue growth | 26% YoY consolidated; Care Health grew 37% in GWP terms. |
|---|---|
| Margins | Care Health combined ratio at 102.6%, aiming for 100% in 2 years. |
| Order book | NBFC/HFC book size ambitions of ₹10,000-15,000 Cr with fresh capital. |
| Demand visibility | Strong structural tailwinds in affordable housing; land-grab moment in health insurance. |
| Management confidence | High in insurance; repairing mode for broking and lending segments. |
Growth
Consolidated revenue up 26%; Broking PBT grew 53% YoY; Care Health GWP grew 37% YoY.
Outlook
Ambitious goal of ₹10,000-15,000 Cr book size for lending; Care aiming for 100% combined ratio in 2 years.
Risks
RBI rejected demerger application; high competitive intensity in health insurance; transition period for lending businesses.
Last quarter's promises, checked
Delivered
- Guided Care GWP growth better than industry → delivered 37% vs 30% (= BEAT)
- Guided Care combined ratio improvement → delivered 120 bps reduction to 101.4% (= BEAT)
- Guided NBFC/Broking profitability → delivered PAT of ₹139 Cr and ₹23 Cr respectively (= BEAT)
Partly delivered
- Guided Care combined ratio near 100% → delivered 102.6% in current call (= PARTIAL)
Missed
- Guided demerger scheme implementation → delivered RBI rejection of application (= MISS)
Earnings Call Transcript filed with BSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹242.27
- Market cap
- ₹8,352 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- 360.0×Sector 22.0×
- Promoter holding
- 30.56%+0.29% QoQ
- FII holding
- 9.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Annual General Meeting
Religare Enterprises Limited held its 42nd Annual General Meeting on September 24, 2026, where members adopted financial statements and approved the re-designation of Mr. Arjun Lamba.
Religare Enterprises Debt & Borrowing: ₹100 Cr
Religare Enterprises' subsidiary, Care Health Insurance Limited, has allotted non-convertible debentures aggregating to ₹100 Crore. These securities will be listed on the NSE.
- Value
- ₹100.0 Cr
Religare Enterprises Other Announcement
Religare Enterprises Limited has approved the continuation of Mr. Rajender Mohan Malla as the Non-Executive Chairperson for the quarter ending December 31, 2026.
Religare Enterprises Investor Presentation: Key Takeaways
Religare reported Q1 FY27 consolidated revenue of Rs. 2,358.4 Cr, up 26% YoY, driven by strong performance in the Insurance segment. Net profit turned into a loss of Rs. 46.9 Cr.
Religare Enterprises Q1 FY27 Results: Net Loss of ₹9.6 Cr, Loss Widens
Religare Enterprises Ltd reported revenue from operations of ₹2.5 Cr (+1150.0% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹9.6 Cr
Religare Enterprises Q1 FY27 Results: Net Loss of ₹47 Cr
Religare Enterprises Ltd reported revenue from operations of ₹2,353 Cr (+25.7% YoY) and a net loss of ₹47 Cr for Q1 FY27.
- Key figure
- Net loss ₹47 Cr